PoliticalRepoPoliticalRepo

Jurisdiction

United States

United States of America

Federal congressional records via Congress.gov. State legislation will use separate providers.

Institutions

United States Congress

Official website

United States House of Representatives

Official website

United States Senate

Official website

Record types

Recent records

View all 10,077
Bill· HRH.R. 5334 (119th)open

Lindsey O. Graham Sanctioning Russia and Iran Act of 2026

United States · United States Congress · 11 September 2025

Supporting Early-childhood Educators' Deductions Act of 2025 or the SEED Act of 2025 This bill expands eligibility for the above-the-line federal tax deduction for certain eligible educator expenses to include early childhood educators. (An above-the-line tax deduction is subtracted from gross income to calculate adjusted gross income.) Under current law, kindergarten through grade 12 teachers, instructors, counselors, principals, or aides in schools that provide elementary or secondary education are allowed an above-the-line tax deduction of up to $300 (in 2025 and adjusted annually) for certain unreimbursed professional development and classroom expenses. (Other conditions apply.) The bill expands eligibility for the tax deduction for such educator expenses to include early childhood educators in schools that provide early childhood (pre-kindergarten) education. 

Bill· HRH.R. 3925 (119th)open

Yuhaaviatam of San Manuel Nation Land Exchange Act

United States · United States Congress · 11 June 2025

Yuhaaviatam of San Manuel Nation Land Exchange Act This bill authorizes a land exchange between the Yuhaaviatam of San Manuel Nation (also federally recognized as the San Manuel Band of Mission Indians) and the federal government. The tribe is located on the San Manuel Indian Reservation near the cities of Highland and San Bernardino in California. Specifically, if the tribe offers to convey to the federal government all right, title, and interest of the tribe in and to approximately 1,460 acres of land, then the Forest Service must accept the offer and convey all right, title, and interest of the federal government in and to approximately 1,475 acres of National Forest System land. The Forest Service must accept the offer and convey the land as soon as practicable within 120 days of receiving the offer. As a condition of the land exchange, within 120 days of the bill's enactment, the tribe must enter into an agreement with the Forest Service under which the tribe agrees to preserve the historical and cultural integrity of the Arrowhead landmark site. The site is located in the foothills of the San Bernardino Mountains directly above San Bernardino, California. Land acquired by the Forest Service shall become part of the San Bernardino National Forest.

Bill· HRH.R. 2827 (119th)open

To provide for the equitable settlement of certain Indian land disputes regarding land in Illinois, and for other purposes.

United States · United States Congress · 10 April 2025

This bill confers jurisdiction to the U.S. Court of Federal Claims for the Miami Tribe of Oklahoma's land claim arising under the Treaty of Grouseland. The court must render judgement without regard to the statute of limitations or any delay-based defense. This jurisdiction expires unless such a claim is filed within one year. All other claims, including any future claims, of the tribe to land in Illinois are extinguished.

Bill· SS. 545 (119th)open

Combating Illicit Xylazine Act

United States · United States Congress · 12 February 2025

Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused. Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA. The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs. The bill also exempts xylazine manufacturers from the CSA's physical security requirements. Finally, the bill requires the DEA, in coordination with the Department of Health and Human Services (HHS), to provide Congress with a report on how the agencies previously determined whether xylazine should be a controlled substance, including the full text of HHS's recommendations to the DEA for scheduling xylazine.

Bill· SS. 929 (119th)referred

GATE Act of 2025

United States · United States Congress · 11 March 2025

Bill· HRH.R. 3747 (119th)referred

Accelerating Access to Dementia and Alzheimer’s Provider Training Act

United States · United States Congress · 5 June 2025

Accelerating Access to Dementia and Alzheimer’s Provider Training Act or the AADAPT Act This bill reauthorizes through FY2031 and revises the Technology-enabled Collaborative Learning Program, which is administered by the Health Resources and Services Administration. This program provides grants to support the use of technology that connects different health care professionals to improve access to health care, including specialty care, for certain rural and medically underserved populations.  The bill explicitly adds dementia care to the types of specialty care that the program may address.

Bill· HRH.R. 5160 (119th)open

Stem Cell Therapeutic and Research Reauthorization Act of 2025

United States · United States Congress · 4 September 2025

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Bill· HRH.R. 5210 (119th)reported

To make technical amendments to update statutory references to certain provisions classified to title 2, United States Code, title 50, United States Code, and title 52, United States Code, and to correct related technical errors.

United States · United States Congress · 8 September 2025

This bill makes technical amendments to various titles of the U.S. Code to reflect reclassification of provisions of Title 2 (The Congress), Title 50 (War And National Defense), and Title 52 (Voting And Elections). (Reclassification is the transfer of provisions from one place in the code to another.) 

Bill· HRH.R. 3553 (119th)reported

BRUSH Fires Act

United States · United States Congress · 21 May 2025

Bill· HRH.R. 309 (119th)open

National Law Enforcement Officers Remembrance, Support, and Community Outreach Act

United States · United States Congress · 9 January 2025

National Law Enforcement Officers Remembrance, Support and Community Outreach Act. [ sic ] This bill temporarily directs the Department of the Interior to award a grant to the National Law Enforcement Officers Memorial Fund for the expenses associated with operating and enhancing the community outreach, public education, and officer safety and wellness programs of the National Law Enforcement Museum.

Bill· HRH.R. 4863 (119th)referred

Fairness for Khobar Act of 2025

United States · United States Congress · 1 August 2025

Fairness for Khobar Act of 2025 This bill authorizes lump sum catch-up payments from the United States Victims of State Sponsored Terrorism (USVSST) Fund to certain victims of the 1983 Beirut barracks bombing or the 1996 Khobar Towers bombing who did not apply for catch-up payments during the application period. The USVSST Fund is administered by the Department of Justice (DOJ) and provides compensation to certain U.S. persons injured in acts of international state sponsored terrorism and their immediate family members. The Fairness for 9/11 Families Act, enacted in 2022, authorized and provided funding for lump sum catch-up payments from the USVSST Fund to victims of the 1983 Beirut barracks bombing or the 1996 Khobar Towers bombing. Claimants who were previously found eligible for regular payment distributions from the USVSST Fund were also eligible for lump sum payments, but the act required them to apply from December 29, 2022, to June 27, 2023. In a 2024 report, the Government Accountability Office found that up to 274 eligible victims did not apply for lump sum catch-up payments because of DOJ guidance that stated, in part, that claimants who were previously found eligible for regular payment distributions are not eligible for the lump sum catch-up payments.

Bill· HRH.R. 2450 (119th)referred

Prescription Drug Transparency and Affordability Act

United States · United States Congress · 27 March 2025

Prescription Drug Transparency and Affordability Act This bill requires pharmacy benefit managers (PBMs) to report, at least once every six months, prescription drug pricing, payment, and utilization data to the health insurance plans for which the PBM provides services. Specifically, a PBM contracted to provide services to an employer or sponsor offering a large group health insurance plan (i.e., a plan with at least 100 employees or participants) must report to the plan certain information for prescription drug claims under the plan. This includes, for each drug, the difference between the compensation paid by the plan to the PBM and the compensation paid by the PBM to the pharmacy. Further, for each therapeutic class of drugs under the plan, a PBM must report (1) the total amount it received in rebates, fees, and discounts; and (2) the net spending for each class after such rebates, fees, and discounts. Each PBM also must report certain information about (1) drugs for which total spending exceeded $10,000; and (2) drugs dispensed through pharmacies affiliated with the plan or PBM, such as the percentage of prescriptions dispensed by such affiliates. Finally, a PBM providing services to any group health insurance plan must provide the plan with a summary document that includes similar information for prescription drug claims under the plan, as determined by the Department of Health and Human Services. Plans must also make certain aggregate summary information available to plan participants. PBMs and plans that violate these requirements are subject to civil penalties.

Documents

View all 16,870